APP and Alzheimer disease: In contrast, cerebrospinal fluid TMAO levels have been indicated as predictive of cognitive decline in Alzheimer’s disease [28], while suppression of microbial TMA/TMAO production improves cognitive function in the murine APP/PS1 model of Alzheimer’s disease [29].